Tawna L. Mangosh

Tawna L. Mangosh

Auto-generated profile, based on publicly available information

Tawna L. Mangosh

Case Western Reserve Univ

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
TMTawna L. Mangosh
Tawna L. Mangosh
WAWisam N. Awadallah
Wisam N. Awadallah
MGMagdalena M. Grabowska
Magdalena M. Grabowska
DTDerek J. Taylor
Derek J. Taylor
In advanced prostate cancer, resistance to androgen deprivation therapy is achieved through numerous mechanisms, including loss of the androgen receptor (AR) allowing for AR-independent growth. Therapeutic options are limited for AR-independent castration-resistant prostate cancer (CRPC), and defining mechanisms critical for survival is of utmost importance for targeting this lethal disease. Our studies focus on identifying telomere maintenance mechanism (TMM) hallmarks adopted by CRPC to promote survival. TMMs are responsible for telomere elongation to instill replicative immortality and prevent senescence, with the two TMM pathways available being telomerase and alternative lengthening of telomeres (ALT). Here, we show that AR-independent CRPC demonstrates an atypical ALT-like phenotype with variable telomerase expression and activity, whereas AR-dependent models lack discernible ALT hallmarks. In addition, AR-independent CRPC cells exhibited elevated levels of SLX4IP, a protein implicated in promoting ALT. SLX4IP overexpression in AR-dependent C4-2B cells promoted an ALT-like phenotype and telomere maintenance. SLX4IP knockdown in AR-independent DU145 and PC-3 cells led to ALT-like hallmark reduction, telomere shortening, and induction of senescence. In PC-3 xenografts, this effect translated to reduced tumor volume. Using an in vitro model of AR-independent progression, loss of AR in AR-dependent C4-2B cells promoted an atypical ALT-like phenotype in an SLX4IP-dependent manner. Insufficient SLX4IP expression diminished ALT-like hallmarks and resulted in accelerated telomere loss and senescence. Implications: This study demonstrates a unique reliance of AR-independent CRPC on SLX4IP-mediated ALT-like hallmarks and loss of these hallmarks induces telomere shortening and senescence, thereby impairing replicative immortality.

18 May 2023 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
TMTawna Mangosh
Tawna Mangosh
ID 23747 Poster Board 396 At Case Western Reserve University, self-directed learning serves as the cornerstone of medical education. To ensure students are trained for their future careers as life-long learners, first- and second-year medical students engage in Problem-based Learning (PBL) to cultivate their skills. Despite the current inclusion of pharmacology throughout the PBL curriculum, student satisfaction as it relates to their pharmacology education continues to fall short of faculty expectations. Efforts must be made to develop innovative learning opportunities to foster self-directed pharmacology learning and improve student satisfaction and exam performance in this area. The purpose of this study is to determine if the introduction of pharmacology learning objectives and novel video resources for each PBL case improves student satisfaction and learning outcomes related to pharmacology education. New learning objectives are being mapped to pharmacology resource videos created by our faculty via the Notability application. Videos address pathophysiology, drug mechanisms, and important pharmacologic considerations relevant to each existing PBL case. Using Notability, these teaching resources can be repurposed by the students to practice recalling and applying their knowledge. Students are being asked to rate their satisfaction with these learning opportunities at the conclusion of each course and provide comments for qualitative analysis. In the future, pharmacology-related summative assessments will be examined and compared to cohorts who did not receive the pharmacology learning objectives or video resources. Additionally, student perception ratings of clinical preparedness regarding pharmacology education on the AAMC Graduation Questionnaire will be compared with previous years upon graduation of the first cohort with this intervention. Data collection is ongoing but initial student feedback is encouraging. Student satisfaction data has been collected for one major curricular block of the pre-clerkship phase. Of the students (n=105) that rated the educational effectiveness of the pharmacology resource videos, over 95% of students indicated the videos were either effective, very effective, or extremely effective. Notably over 70% of students indicated the videos were extremely effective. Additionally, student comments were classified as either positive or negative and thematic comment analysis revealed six themes. Most comments were positive and aligned with the themes of excitement and appreciation, effective explanation of complex concepts, curricular alignment of content, quality visual resource, and clinically relevant pharmacology focus. The limited number of negative comments aligned with the themes of technology barriers and curricular alignment of content. To complement these findings, satisfaction ratings and exam performance from subsequent curricular blocks are being collected and analyzed. The integration of pharmacology learning objectives and the development of Notability-based pharmacology resources received an overwhelmingly positive response. Moving forward, these resources will continue to help guide student’s self-directed learning thereby improving student satisfaction and learning outcomes in their pharmacology education.


1 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
TMTawna L. Mangosh
Tawna L. Mangosh
WAWisam N. Awadallah
Wisam N. Awadallah
MGMagdalena M. Grabowska
Magdalena M. Grabowska
DTDerek J. Taylor
Derek J. Taylor
In advanced prostate cancer, resistance to androgen deprivation therapy is achieved through numerous mechanisms, including loss of the androgen receptor (AR) allowing for AR-independent growth. Therapeutic options are limited for AR-independent castration-resistant prostate cancer, and defining mechanisms critical for its survival is of utmost importance for targeting this lethal disease. Our studies have focused on defining the telomere maintenance mechanism (TMM) required for castration-resistant prostate cancer (CRPC) cell survival. TMMs are responsible for telomere elongation to instill replicative immortality and prevent senescence, with the two TMM pathways available being telomerase and alternative lengthening of telomeres (ALT). Here, we show that AR-independent CRPC exhibits ALT hallmarks and limited telomerase expression and activity, whereas AR-dependent models use telomerase for telomere maintenance. AR-independent CRPC exhibited elevated levels of SLX4IP, a protein implicated in TMM switching. SLX4IP overexpression in AR-dependent CRPC C4-2B cells promoted ALT hallmarks in vitro . SLX4IP knockdown in AR-independent CRPC cells (DU145 and PC-3) led to the loss of ALT hallmarks, dramatic telomere shortening, induction of senescence, and reduced tumor volume. Using an in vitro model of CRPC progression, induction of neuroendocrine differentiation in AR-dependent CRPC cells promoted ALT hallmarks in an SLX4IP-dependent manner. Lack of sufficient SLX4IP expression prevented ALT hallmarks rendering a TMM deficient environment, thus inducing senescence. This study demonstrates a unique reliance of AR-independent CRPC on SLX4IP-mediated ALT. Furthermore, ALT hallmark inhibition via SLX4IP induces senescence, thereby abolishing the replicative immortality of AR-independent CRPC.

3 April 2023
Verified
Other
Open access
TMTawna L. Mangosh
Tawna L. Mangosh
WAWisam N. Awadallah
Wisam N. Awadallah
MGMagdalena M. Grabowska
Magdalena M. Grabowska
DTDerek J. Taylor
Derek J. Taylor
In advanced prostate cancer, resistance to androgen deprivation therapy is achieved through numerous mechanisms, including loss of the androgen receptor (AR) allowing for AR-independent growth. Therapeutic options are limited for AR-independent castration-resistant prostate cancer (CRPC), and defining mechanisms critical for survival is of utmost importance for targeting this lethal disease. Our studies focus on identifying telomere maintenance mechanism (TMM) hallmarks adopted by CRPC to promote survival. TMMs are responsible for telomere elongation to instill replicative immortality and prevent senescence, with the two TMM pathways available being telomerase and alternative lengthening of telomeres (ALT). Here, we show that AR-independent CRPC demonstrates an atypical ALT-like phenotype with variable telomerase expression and activity, whereas AR-dependent models lack discernible ALT hallmarks. In addition, AR-independent CRPC cells exhibited elevated levels of SLX4IP, a protein implicated in promoting ALT. SLX4IP overexpression in AR-dependent C4-2B cells promoted an ALT-like phenotype and telomere maintenance. SLX4IP knockdown in AR-independent DU145 and PC-3 cells led to ALT-like hallmark reduction, telomere shortening, and induction of senescence. In PC-3 xenografts, this effect translated to reduced tumor volume. Using an in vitro model of AR-independent progression, loss of AR in AR-dependent C4-2B cells promoted an atypical ALT-like phenotype in an SLX4IP-dependent manner. Insufficient SLX4IP expression diminished ALT-like hallmarks and resulted in accelerated telomere loss and senescence.Implications:This study demonstrates a unique reliance of AR-independent CRPC on SLX4IP-mediated ALT-like hallmarks and loss of these hallmarks induces telomere shortening and senescence, thereby impairing replicative immortality.

3 April 2023
Verified
Other
Open access
TMTawna L. Mangosh
Tawna L. Mangosh
WAWisam N. Awadallah
Wisam N. Awadallah
MGMagdalena M. Grabowska
Magdalena M. Grabowska
DTDerek J. Taylor
Derek J. Taylor
S1: Validation of TMM characterization techniques. S2: Expression of SLX4IP in mCRPC versus primary disease. S3: SLX4IP knockdown correlates with accelerated telomere shortening. S4: SLX4IP knockdown is accompanied by a blunted atypical ALT phenotype. S5: SLX4IP knockdown promotes telomere shortening and senescence. S6: Androgen-independent marker expression and telomere length changes following androgen deprivation.